PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.04%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-13.64%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-18.51%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-18.97%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-19.78%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-20.21%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-19.46%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
4.88%
Dividend growth above 1.5x MRVL's 0.22%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-0.67%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
75.57%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
61.04%
10Y revenue/share CAGR above 1.5x MRVL's 12.64%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
15.12%
5Y revenue/share CAGR under 50% of MRVL's 33.23%. Michael Burry would suspect a significant competitive gap or product weakness.
1.24%
3Y revenue/share CAGR under 50% of MRVL's 54.02%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
91.92%
10Y OCF/share CAGR above 1.5x MRVL's 5.77%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-5.86%
Negative 5Y OCF/share CAGR while MRVL is at 69.67%. Joel Greenblatt would question the firm’s operational model or cost structure.
-8.36%
Negative 3Y OCF/share CAGR while MRVL stands at 390.54%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
220.89%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
16.14%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
-17.80%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
87.00%
10Y equity/share CAGR at 75-90% of MRVL's 114.66%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
97.18%
5Y equity/share CAGR at 75-90% of MRVL's 118.24%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
86.15%
3Y equity/share CAGR above 1.5x MRVL's 40.41%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
333.29%
Stable or rising dividend while MRVL is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
68.41%
Stable or rising mid-term dividends while MRVL is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
27.57%
Our short-term dividend growth is positive while MRVL cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-9.56%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.33%
Inventory shrinking or stable vs. MRVL's 11.57%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.24%
Asset growth of 2.24% while MRVL is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
1.60%
BV/share growth above 1.5x MRVL's 0.33%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
5.05%
We have some new debt while MRVL reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-2.34%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-3.10%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.